TYFEGRAL, created in 2014 (Sweden), from 585 sister brands and 17478 competing brands. The TYFEGRAL brand is owned by ASTRAZENECA, a company listed in London. The ISIN, the company's International Securities Identification Number, is GB0009895292. TYFEGRAL is part of the Drug Manufacturers activity sector.